文献速递主动脉疾病

装置类型与胸主动脉腔内修复术后IIIb型内漏的相关性

Association Between Device Type and Type IIIb Endoleaks Following Thoracic Endovascular Aortic Repair.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2022-10-06

本研究基于FDA的MAUDE数据库2010至2020年7328份胸主动脉支架报告,用比例报告比(PRR)和卡方检验分析装置类型与IIIb型内漏(T3bE)的关联信号。Medtronic Valiant装置PRR最高为2.07(95%CI 1.72-2.42,2520份报告中64例T3bE),卡方值17.3,该关联最早可追溯至2013年。杜克大学医院2002年以来542例动脉瘤指征TEVAR中发生8例T3bE,均见于缝合型织物覆膜装置。

要点

  • Medtronic Valiant装置在MAUDE数据库中满足与T3bE关联的标准,且最早于2013年即可识别该信号。
  • Gore CTAG的PRR最低为0.36(95%CI 0-1.03,1328份报告中9例T3bE)。
  • 本机构542例TEVAR中8例T3bE均发生于缝合型织物覆膜装置。

核心结论

  • Medtronic Valiant装置在FDA的MAUDE数据库中满足与IIIb型内漏关联的标准,且最早于2013年即满足该标准。
  • 本机构大量TEVAR中发生的所有类型T3bE均发生于缝合型织物覆膜装置置入后,支持编织覆膜织物与T3bE之间可能存在关系。

研究设计与样本

  • 回顾FDA的MAUDE数据库中2010至2020年间与胸主动脉支架相关的报告,共7328份可供分析。
  • 同时查询本机构自2002年以来因胸主动脉瘤行TEVAR的患者数据库中的T3bE。

主要发现

  • MAUDE数据库分析中,T3bE的PRR最低为0.36(95%CI 0-1.03,Gore CTAG,1328份报告中9例T3bE),最高为2.07(95%CI 1.72-2.42,Medtronic Valiant,2520份报告中64例T3bE)。
  • Medtronic Valiant的T3bE卡方值为17.3,该关联最早可追溯至2013年。
  • 杜克大学医院自2002年以来542例动脉瘤指征TEVAR中发生8例T3bE,全部见于缝合型织物覆膜装置。

关键数值与推荐

  • PRR>2且卡方值>4、总报告数≥3构成关联信号。
  • Medtronic Valiant的PRR为2.07(95%CI 1.72-2.42),卡方值17.3。
  • Gore CTAG的PRR为0.36(95%CI 0-1.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endoleaks following thoracic endovascular aortic repair (TEVAR) can lead to the need for re-intervention and aortic rupture. Given the recent recall of a specific thoracic stent graft type due to concerns about type IIIb endoleak (T3bE), in which blood leaks through the stent graft fabric, the aim was to characterise patterns of T3bEs among available TEVAR devices. METHODS: Reports related to thoracic stent grafts in the Food and Drug Administration's (FDA) Manufacturer and User Facility Device Experience (MAUDE) database between 2010 and 2020 were reviewed. Proportional reporting ratios (PRRs) and chi squared tests were used to assess for the presence of a signal of association between device type and T3bE. A PRR > 2 and chi squared value > 4 with three or more reports overall constituted a signal of association. The institutional database of patients undergoing TEVAR for thoracic aneurysms since 2002 was also queried for T3bE. RESULTS: There were 7 328 MAUDE reports available for analysis. When analysing T3bEs in the MAUDE database, the lowest PRR was 0.36 (95% confidence interval [CI] 0 - 1.03 in Gore CTAG, nine T3bE among 1 328 reports) and the highest was 2.07 (95% CI 1.72 - 2.42 in Medtronic Valiant, 64 T3bE among 2 520 reports). The T3bE chi squared value for Medtronic Valiant was 17.3. The relationship between Medtronic Valiant and T3bE was ascertainable by MAUDE data as early as 2013. Among 542 TEVARs for an aneurysm indication at Duke University Hospital since 2002, there were eight T3bEs - all in devices with sutured on graft material. CONCLUSION: The Medtronic Valiant device met criteria for association with type IIIb endoleaks in the FDA's MAUDE database and met those criteria as early as 2013. A possible relationship between woven graft fabric and T3bEs is supported by the observation that all types of T3bE that occurred among a large number of TEVARs at the institution followed placement of grafts with sutured on woven fabric.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Weissler EH, Hammill BG, Armstrong JL, et al. Association Between Device Type and Type IIIb Endoleaks Following Thoracic Endovascular Aortic Repair. Eur J Vasc Endovasc Surg. 2022. PMID: 36209962. doi:10.1016/j.ejvs.2022.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。